b 544
Pill imprint b 544 has been identified as Terbinafine 250 mg.
Terbinafine is used in the treatment of tinea corporis; onychomycosis, toenail; cutaneous candidiasis; tinea pedis; tinea capitis (and more), and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy.
Terbinafine 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Terbinafine Images
- Imprint:
-
b
544 - Strength:
- 250 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
Advertisement
More Terbinafine resources
- Terbinafine (Wolters Kluwer)
- Terbinafine Granules (Wolters Kluwer)
- terbinafine (Cerner Multum)
- Terbinex (Micromedex) - Includes Dosage Information
- terbinafine (Micromedex) - Includes Dosage Information
- Terbinafine Hydrochloride (AHFS DI)
- Terbinafine (FDA)
- Terbinex (FDA)
Search Again
